During the past decade, Ecclesfield group Practice conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ecclesfield group Practice" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials), "Cough" (1 trials), "Dyslipidemic" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Ecclesfield group Practice" in a lesser frequency.

Most popular intervention types in "Ecclesfield group Practice" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "BC1036" (1 trials), "Non-interventional" (1 trials), "Telmisartan 20 mg/amlodipine 2.5 mg ." (1 trials) and "Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ecclesfield group Practice" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ecclesfield group Practice". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ecclesfield group Practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ecclesfield group Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".